MDS clinical diagnostic criteria for Parkinson’s disease

Cited by (1,019)

Items 901–1,000 of 1,019

1. Is there a role for ghrelin in central dopaminergic systems? Focus on nigrostriatal and mesocorticolimbic pathways
   Stievenard, Alicia, Méquinion, Mathieu, Andrews, Zane B., Destée, Alain, Chartier-Harlin, Marie-Christine, Viltart, Odile, Vanbesien-Mailliot, Christel C. · 2017 · Neuroscience & Biobehavioral Reviews
2. Comorbid alpha synucleinopathies in idiopathic normal pressure hydrocephalus
   Anri Sakurai, Taiji Tsunemi, Yuta Ishiguro, Ayami Okuzumi, Taku Hatano, Nobutaka Hattori · 2021 · Journal of Neurology
3. Dual-task clinical and functional MRI correlates in Parkinson's disease with postural instability and gait disorders
   Elisabetta Sarasso, Andrea Gardoni, Noemi Piramide, Maria Antonietta Volonté, Elisa Canu, Andrea Tettamanti, Massimo Filippi, Federica Agosta · 2021 · Parkinsonism & Related Disorders
4. Dopaminergic imaging in degenerative parkinsonisms, an established clinical diagnostic tool
   Nicolas Nicastro, Umberto Nencha, Pierre R. Burkhard, Valentina Garibotto · 2021 · Journal of Neurochemistry
5. New Understanding on the Pathophysiology and Treatment of Constipation in Parkinson’s Disease
   Jianli Xu, Lei Wang, Xi Chen, Weidong Le · 2022 · Frontiers in Aging Neuroscience
6. Dysregulation of peripheral monocytes and pro-inflammation of alpha-synuclein in Parkinson’s disease
   Yun Su, Changhe Shi, Tai Wang, Chen Liu, Jing Yang, Shuyu Zhang, Liyuan Fan, Huimin Zheng, Xinwei Li, Haiyang Luo et al. · 2022 · Journal of Neurology
7. Rigidity in Parkinson’s disease: evidence from biomechanical and neurophysiological measures
   Francesco Asci, Marco Falletti, Alessandro Zampogna, Martina Patera, Mark Hallett, John C. Rothwell, Antonio Suppa · 2023 · Brain
8. Altered nucleus accumbens functional connectivity precedes apathy in Parkinson’s disease
   Lee‐Anne Morris, Samuel J. Harrison, Tracy R. Melzer, John C. Dalrymple‐Alford, Tim Anderson, Michael R MacAskill, Campbell J. Le Heron · 2023 · Brain
9. CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease
   Lorenzo Barba, Samir Abu‐Rumeileh, Steffen Halbgebauer, Giovanni Bellomo, Federico Paolini Paoletti, Lorenzo Gaetani, Patrick Oeckl, Petra Steinacker, Federico Massa, Lucilla Parnetti et al. · 2023 · Neurology
10. Denoising approach with deep learning-based reconstruction for neuromelanin-sensitive MRI: image quality and diagnostic performance
    Sonoko Oshima, Yasutaka Fushimi, Kanae Kawai Miyake, Satoshi Nakajima, Akihiko Sakata, Sachi Okuchi, Takuya Hinoda, Sayo Otani, Hitomi Numamoto, Koji Fujimoto et al. · 2023 · Japanese Journal of Radiology
11. Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)
    Clodagh Towns, Madeleine Richer, Simona Jasaityte, Eleanor J. Stafford, Julie Joubert, Tarek Antar, Alejandro Martínez-Carrasco, Mary B. Makarious, Bradford H. Casey, Dan Vitale et al. · 2023 · npj Parkinson s Disease
12. Glutathione Depletion and Concomitant Elevation of Susceptibility in Patients with Parkinson’s Disease: State-of-the-Art MR Spectroscopy and Neuropsychological Study
    Deepika Shukla, Anshika Goel, Pravat Kumar Mandal, Shallu Joon, Khushboo Punjabi, Yashika Arora, Rajnish Kumar, Veer Singh Mehta, Padam Singh, Joseph C. Maroon et al. · 2023 · ACS Chemical Neuroscience
13. Intelligent Identification of Cerebrospinal Fluid for the Diagnosis of Parkinson’s Disease
    Huiting Chen, Siyun Guo, Zehong Zhuang, Sixue Ouyang, Peiru Lin, Zhiyuan Zheng, Yuanyuan You, Xiang Yu Zhou, Yuan Li, Jiajia Lu et al. · 2024 · Analytical Chemistry
14. Alterations of p11 in brain tissue and peripheral blood leukocytes in Parkinson’s disease
    Holly Green, Xiaoqun Zhang, Katarína Tiklová, Nikolaos Volakakis, Lovisa Brodin, Louise Berg, Paul Greengard, Thomas Perlmann, Per Svenningsson · 2017 · Proceedings of the National Academy of Sciences
15. Differentiation of atypical Parkinson syndromes
    Günter U. Höglinger, Jan Kassubek, Ilona Csóti, Reinhard Ehret, Heinz Herbst, Ingmar Wellach, Jürgen Winkler, Wolfgang H. Jost · 2017 · Journal of Neural Transmission
16. Molecular Imaging and Updated Diagnostic Criteria in Lewy Body Dementias
    Nicolaas Ida Bohnen, Martijn L.T.M. Müller, Kirk A. Frey · 2017 · Current Neurology and Neuroscience Reports
17. Cognitive Impact of Deep Brain Stimulation on Parkinson’s Disease Patients
    Raja Mehanna, Jawad A. Bajwa, Hubert H. Fernandez, Aparna Wagle Shukla · 2017 · Parkinson s Disease
18. Alterations of NURR1 and Cytokines in the Peripheral Blood Mononuclear Cells: Combined Biomarkers for Parkinson’s Disease
    Tianbai Li, Zhaofei Yang, Song Li, Cheng Cheng, Bairong Shen, Weidong Le · 2018 · Frontiers in Aging Neuroscience
19. Lewy Body Dementias
    Melissa J. Armstrong · 2019 · CONTINUUM Lifelong Learning in Neurology
20. Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study
    Andrea Calvo, Adriano Chiò, Marco Pagani, Stefania Cammarosano, Francesca Dematteis, Cristina Moglia, Luca Solero, Umberto Manera, Tiziana Martone, Maura Brunetti et al. · 2019 · Journal of Neurology
21. The diagnostic value of SNpc using NM-MRI in Parkinson’s disease: meta-analysis
    Xiangming Wang, Yuehui Zhang, Chen Zhu, Guangzong Li, Jie Kang, Fang Chen, Ling Yang · 2019 · Neurological Sciences
22. Technology-Based Objective Measures Detect Subclinical Axial Signs in Untreated, de novo Parkinson’s Disease
    Giulia Di Lazzaro, Mariachiara Ricci, Mohammad Sami Al-Wardat, Tommaso Schirinzi, Simona Scalise, Franco Giannini, Nicola Biagio Mercuri, Giovanni Saggio, Antonio Pisani · 2019 · Journal of Parkinson s Disease
23. Plasma exosomal prion protein levels are correlated with cognitive decline in PD patients
    Bing Leng, Hairong Sun, Junwu Zhao, Yuanyuan Liu, Tengqun Shen, Wenjing Liu, Xiaoxiao Liu, Ming Tan, Fang Li, Jinbiao Zhang et al. · 2020 · Neuroscience Letters
24. Parkinson’s Disease: Available Clinical and Promising Omics Tests for Diagnostics, Disease Risk Assessment, and Pharmacotherapy Personalization
    Oxana P. Trifonova, Dmitry L. Maslov, Elena E. Balashova, Уразгильдеева Гузель Рашидовна, Д. А. Абаимов, E. Yu. Fedotova, Vsevolod V. Poleschuk, Sergey Nikolaevich Illarioshkin, Petr G. Lokhov · 2020 · Diagnostics
25. Microsleep disturbances are associated with noradrenergic dysfunction in Parkinson’s disease
    Christopher E. J. Doppler, Julia A M Smit, Maximilian Hommelsen, Aline Seger, Jacob Horsager, Martin Byskov Kinnerup, Allan K. Hansen, Tatyana Dmitrievna Fedorova, Karoline Knudsen, Marit Otto et al. · 2021 · SLEEP
26. Accuracy of Cardiac Innervation Scintigraphy for Mild Cognitive Impairment With Lewy Bodies
    Gemma Roberts, Rory Durcan, Paul C. Donaghy, Sarah Lawley, Joanna Ciafone, Calum Alexander Hamilton, Sean J. Colloby, Michael Firbank, Louise M. Allan, Nicola A. Barnett et al. · 2021 · Neurology
27. Neocortical Lewy Body Pathology Parallels Parkinson's Dementia, but Not Always
    W. R. Wayne Martin, John R. Younce, Meghan C. Campbell, Brad Alan Racette, Scott A. Norris, Mwiza Ushe, Susan R. Criswell, Albert A. Davis, Isabel Alfradique‐Dunham, Baijayanta Maiti et al. · 2022 · Annals of Neurology
28. Changes in Gastrointestinal Microbiome Composition in PD: A Pivotal Role of Covariates
    Cosma-Grigorov, Alexandra, Meixner, Holger, Mrochen, Anne, Wirtz, Stefan, Winkler, Jürgen, Marxreiter, Franz · 2020 · Frontiers in Neurology
29. A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias
    Bolsewig, Katharina, Hok-A-Hin, Yanaika S., Sepe, Federica N., Boonkamp, Lynn, Jacobs, Dirk, Bellomo, Giovanni, Paoletti, Federico Paolini, Vanmechelen, Eugeen, Teunissen, Charlotte E., Parnetti, Lucilla et al. · 2022 · Journal of Alzheimer's Disease
30. Clinical Outcome and Striatal Dopaminergic Function After Shunt Surgery in Patients With Idiopathic Normal Pressure Hydrocephalus
    Massimiliano Todisco, Roberta Zangaglia, Brigida Minafra, Patrizia Pisano, Giuseppe Trifirò, Irene Bossert, Nicoló Gabriele Pozzi, Joachim Brumberg, Roberto Ceravolo, Ioannis U. Isaias et al. · 2021 · Neurology
31. Differential Amperometric Microneedle Biosensor for Wearable Levodopa Monitoring of Parkinson’s Disease
    Fang Lü, Hangxu Ren, Xiyu Mao, Shanshan Zhang, Yu Cai, Shiyi Xu, Yi Zhang, Lihua Li, Xuesong Ye, Bo Liang · 2022 · Biosensors
32. Treadmill training and physiotherapy similarly improve dual task gait performance: a randomized-controlled trial in Parkinson’s disease
    Heiko Gaßner, Elmar Trutt, Sarah Seifferth, Jana Friedrich, Diana Zucker, Ziad Salhani, Werner Adler, Jürgen Winkler, Wolfgang H. Jost · 2022 · Journal of Neural Transmission
33. Speech acoustic indices for differential diagnosis between Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy
    Khalid Daoudi, Biswajit Das, Tereza Tykalová, Jiří Klempíř, Jan Rusz · 2022 · npj Parkinson s Disease
34. Microbiome–gut–brain dysfunction in prodromal and symptomatic Lewy body diseases
    Sephira G. Ryman, Andrei A. Vakhtin, Sarah Pirio Richardson, Henry C. Lin · 2022 · Journal of Neurology
35. Dysphagia for medication in Parkinson’s disease
    Bendix Labeit, Elijahu Berkovich, Inga Claus, Malte Roderigo, Anna-Lena Schwake, Dvora Izgelov, Dorit Mimrod, Sigrid Ahring, Stephan Oelenberg, Paul Muhle et al. · 2022 · npj Parkinson s Disease
36. Metformin and Trehalose-Modulated Autophagy Exerts a Neurotherapeutic Effect on Parkinsonʼs Disease
    Yareth Gopar‐Cuevas, Odila Saucedo Cárdenas, María de Jesús Loera‐Arias, Roberto Montes‐de‐Oca‐Luna, Humberto Rodríguez‐Rocha, Aracely García‐García · 2023 · Molecular Neurobiology
37. Interplay between the glymphatic system and neurotoxic proteins in Parkinson's disease and related disorders: current knowledge and future directions
    Yumei Yue, Xiaodan Zhang, Wen Lv, Hsin‐Yi Lai, Ting Shen · 2023 · Neural Regeneration Research
38. Isolation and quantification of L1CAM‐positive extracellular vesicles on a chip as a potential biomarker for Parkinson's Disease
    Danyu Li, Siyi Zou, Ziyang Huang, Congcong Sun, Guozhen Liu · 2024 · Journal of Extracellular Vesicles
39. Global trends and projections of Parkinson’s disease incidence: a 30-year analysis using GBD 2021 data
    Libo Xu, Zhenhao Wang, Qingsong Li · 2025 · Journal of Neurology
40. Scan without evidence of dopaminergic deficit: A 10-year retrospective study
    Nicolas Nicastro, Valentina Garibotto, Simon Badoud, Pierre R. Burkhard · 2016 · Parkinsonism & Related Disorders
41. Neuromelanin MRI is useful for monitoring motor complications in Parkinson’s and PARK2 disease
    Taku Hatano, Ayami Okuzumi, Koji Kamagata, Kensuke Daida, Daisuke Taniguchi, Masaaki Hori, Hiroyo Yoshino, Shigeki Aoki, Nobutaka Hattori · 2017 · Journal of Neural Transmission
42. Deep brain stimulation and genetic variability in Parkinson’s disease: a review of the literature
    Johanne Ligaard, Julia Sannæs, Lasse Pihlstrøm · 2019 · npj Parkinson s Disease
43. Autophagic- and Lysosomal-Related Biomarkers for Parkinson’s Disease: Lights and Shadows
    Helena Xicoy, Núria Peñuelas, Miquel Vila, Ariadna Laguna · 2019 · Cells
44. Validation of freely-available pitch detection algorithms across various noise levels in assessing speech captured by smartphone in Parkinson’s disease
    Vojtěch Illner, Pavel Sovka, Jan Rusz · 2020 · Biomedical Signal Processing and Control
45. Magnetic Resonance Parkinsonism Index for evaluating disease progression rate in progressive supranuclear palsy: A longitudinal 2-year study
    Aldo Quattrone, Maurizio Morelli, Andrea Quattrone, Basilio Vescio, Salvatore Lo Nigro, Gennarina Arabia, Rita Nisticò, Fabiana Novellino, Maria Salsone, Pier Paolo Arcuri et al. · 2020 · Parkinsonism & Related Disorders
46. Characterizing vocal tremor in progressive neurological diseases via automated acoustic analyses
    Jan Hlavnička, Tereza Tykalová, Olga Ulmanová, Petr Dušek, Dana Horáková, Evžen Růžička, Jiří Klempíř, Jan Rusz · 2020 · Clinical Neurophysiology
47. Association of Motor and Cognitive Symptoms with Health-Related Quality of Life and Caregiver Burden in a German Cohort of Advanced Parkinson’s Disease Patients
    Martin Klietz, Theresa Schnur, Simon C. Drexel, Florian Lange, A. Tulke, L. Rippena, Lejla Paracka, Dirk W. Dressler, Günter U. Höglinger, Florian Wegner · 2020 · Parkinson s Disease
48. Self‐motion perception in Parkinson's disease
    Orly Halperin, Simon Israeli‐Korn, Sol Yakubovich, Sharon Hassin‐Baer, Adam Zaidel · 2020 · European Journal of Neuroscience
49. Nordic Walking and Walking in Parkinson’s disease: a randomized single-blind controlled trial
    Serena Granziera, Andrea Alessandri, Anna Rosa Lazzaro, Daniela Zara, Alberto Scarpa · 2020 · Aging Clinical and Experimental Research
50. Mean Apparent Propagator MRI Is Better Than Conventional Diffusion Tensor Imaging for the Evaluation of Parkinson’s Disease: A Prospective Pilot Study
    Hongbo Le, Weike Zeng, Huihong Zhang, Jianing Li, Xiaoyan Wu, Mingwei Xie, Xu Yan, Minxiong Zhou, Huiting Zhang, Mengzhu Wang et al. · 2020 · Frontiers in Aging Neuroscience
51. Aberrant Amplitude of Low-Frequency Fluctuations in Different Frequency Bands in Patients With Parkinson’s Disease
    Zhaoxiu Wang, Y. Liu, Xiuhang Ruan, Yuting Li, E. Li, Guoqin Zhang, Mengyan Li, Xinhua Wei · 2020 · Frontiers in Aging Neuroscience
52. Prediction of motor Unified Parkinson's Disease Rating Scale scores in patients with Parkinson’s disease using surface electromyography
    Urs Kleinholdermann, Max Wullstein, David José Pedrosa · 2021 · Clinical Neurophysiology
53. Liposomal Controlled Release Ag-Activated DNAzyme Cycle Amplification on a 2D Pyrene COF-Based Photocathode for α-Synuclein Immunosensing
    Yao Gao, Jinling Zhang, Xuechen Zhang, Jiawen Li, Rui Zhang, Wenbo Song · 2021 · Analytical Chemistry
54. Psychosis in Parkinson’s Disease: Current Treatment Options and Impact on Patients and Caregivers
    Gilad S. Segal, Sophie J Xie, Saif-ur-Rahman Paracha, George Thomas Grossberg · 2021 · Journal of Geriatric Psychiatry and Neurology
55. A Patient-Centered Conceptual Model of Symptoms and Their Impact in Early Parkinson’s Disease: A Qualitative Study
    Hannah Staunton, Kim Kelly, Louise Newton, Mathias Leddin, Raul Rodriguez‐Esteban, К. Ray Chaudhuri, Daniel A. Weintraub, Ronald B. Postuma, Pablo Martínez‐Martín · 2021 · Journal of Parkinson s Disease
56. Brainstem Biomarkers of Clinical Variant and Pathology in Progressive Supranuclear Palsy
    Rosalie M. Grijalva, Nha Trang Thu Pham, Qiao Huang, Peter R. Martin, Farwa Ali, Heather M. Clark, Joseph R. Duffy, Rene L. Utianski, Hugo Botha, Mary M. Machulda et al. · 2021 · Movement Disorders
57. Transcranial Direct Current Stimulation on Parkinson's Disease: Systematic Review and Meta-Analysis
    Paloma Cristina Alves de Oliveira, Thiago Anderson Brito de Araújo, Daniel Gomes da Silva Machado, Abner Cardoso Rodrigues, Marom Bikson, Suellen Marinho Andrade, Alexandre Hideki Okano, Hougelle Simplício Gomes Pereira, Rodrigo Pegado, Edgard Morya · 2022 · Frontiers in Neurology
58. Hand movements in Mild Cognitive Impairment: clinical implications and insights for future research
    Ciro Rosario Ilardi, Alessandro Iavarone, Marco La Marra, Tina Iachini, Sergio Chieffi · 2022 · Journal of Integrative Neuroscience
59. The Chinese Parkinson's Disease Registry ( CPDR ): Study Design and Baseline Patient Characteristics
    Xiaoxia Zhou, Zhenhua Liu, Xiaoting Zhou, Yaqin Xiang, Zhou Zhou, Yuwen Zhao, Hongxu Pan, Qian Xu, Yase Chen, Qiying Sun et al. · 2022 · Movement Disorders
60. Patients with isolated REM-sleep behavior disorder have elevated levels of alpha-synuclein aggregates in stool
    Anja Schaffrath, Sophia Schleyken, Aline Seger, Hannah Jergas, Pelin Özdüzenciler, Marlene Pils, Lara Blömeke, Anneliese Cousin, Johannes Willbold, Tuyen Bujnicki et al. · 2023 · npj Parkinson s Disease
61. Calcium Channel Antagonists as Disease-Modifying Therapy for Parkinson’s Disease: Therapeutic Rationale and Current Status
    T. Swart, Michael J. Hurley · 2016 · CNS Drugs
62. Utility of quantitative EEG in early Lewy body disease
    Massa, Federico, Meli, Riccardo, Grazzini, Matteo, Famà, Francesco, De Carli, Fabrizio, Filippi, Laura, Arnaldi, Dario, Pardini, Matteo, Morbelli, Silvia, Nobili, Flavio · 2020 · Parkinsonism & Related Disorders
63. Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: From biological biomarkers to clinical syndromes
    Carandini, Tiziana, Arighi, Andrea, Sacchi, Luca, Fumagalli, Giorgio G., Pietroboni, Anna M., Ghezzi, Laura, Colombi, Annalisa, Scarioni, Marta, Fenoglio, Chiara, De Riz, Milena A. et al. · 2019 · Alzheimer's Research & Therapy
64. Vascular, flow and perfusion abnormalities in Parkinson's disease
    Chunyan Zhang, Bo Wu, Xiao Wang, Chen Chen, Rui-chen Zhao, Hong Lu, Hongcan Zhu, Bing Xue, Hong Liang, Sean K. Sethi et al. · 2020 · Parkinsonism & Related Disorders
65. TDP ‐43 Proteinopathy Presenting with Typical Symptoms of Parkinson's Disease
    Rika Yamashita, Goichi Beck, Yuki Yonenobu, Kimiko Inoue, Akihiko Mitsutake, Hiroyuki Ishiura, Masato Hasegawa, Shigeo Murayama, Hideki Mochizuki · 2022 · Movement Disorders
66. Shaping the course of early-onset Parkinson’s disease: insights from a longitudinal cohort
    Roberta Bovenzi, Matteo Conti, Giulia Rebecca Degoli, Rocco Cerroni, Clara Simonetta, Claudio Liguori, Chiara Salimei, Antonio Pisani, Mariangela Pierantozzi, Alessandro Stefani et al. · 2023 · Neurological Sciences
67. New horizons in Parkinson’s disease in older populations
    Jagadish Kumar Chhetri, Shanshan Mei, Chaodong Wang, Piu Chan · 2023 · Age and Ageing
68. Diagnostic utility of 7T neuromelanin imaging of the substantia nigra in Parkinson’s disease
    Dhairya A. Lakhani, Xiangzhi Zhou, Shengzhen Tao, Vishal Nainesh Patel, Sijin Wen, Lela Okromelidze, Elena Greco, Chen Lin, Erin M. Westerhold, Sina Straub et al. · 2024 · npj Parkinson s Disease
69. Association of inflammation/nutrition-based indicators with Parkinson’s disease and mortality
    Huafang Jia, Kaixiang Yin, Jihu Zhao, Fengyuan Che · 2024 · Frontiers in Nutrition
70. Oxidative Stress-mediated Lipid Peroxidation-derived Lipid Aldehydes in the Pathophysiology of Neurodegenerative Diseases
    Kieran V Allowitz, Justin Taylor, Kyra Harames, John Yoo, Omar A Baloch, Kota V. Ramana · 2024 · Current Neuropharmacology
71. Optical Hand Tracking: A Novel Technique for the Assessment of Bradykinesia in Parkinson's Disease
    Paulina J.M. Bank, Johan Marinus, Carel G. M. Meskers, Jurriaan H. de Groot, Jacobus Johannes van Hilten · 2017 · Movement Disorders Clinical Practice
72. Altered neurofilament protein expression in the lateral vestibular nucleus in Parkinson’s disease
    Thomas P. Wellings, Alan M. Brichta, Rebecca Lim · 2017 · Experimental Brain Research
73. Protective role of microRNA-221 in Parkinson’s disease
    L. Li, Jianhua Xu, Mianmian Wu, Jianming Hu · 2018 · Bratislavské lekárske listy/Bratislava medical journal
74. Upgraded Methodology for the Development of Early Diagnosis of Parkinson’s Disease Based on Searching Blood Markers in Patients and Experimental Models
    Alexander Kim, Razina Ramazanovna Nigmatullina, Zuleikha A Zalyalova, Natalia V. Soshnikova, А. Н. Краснов, Nadezhda E. Vorobyeva, Sofia G. Georgieva, В. С. Кудрин, Виктор Борисович Наркевич, Michael V. Ugrumov · 2018 · Molecular Neurobiology
75. Mitochondrial Creatine Kinase is Decreased in the Serum of Idiopathic Parkinson’s Disease Patients
    Jinghui Xu, Xiaodi Fu, Mengqiu Pan, Xiao Zhou, Zhaoyu Chen, Dongmei Wang, Xiaomei Zhang, Qiong Chen, Yanhui Li, Xiaoxian Huang et al. · 2018 · Aging and Disease
76. The Parkinson’s phenome—traits associated with Parkinson’s disease in a broadly phenotyped cohort
    Karl Heilbron, Alastair John Noyce, Pierre Fontanillas, Babak Alipanahi, Mike A. Nalls, Michelle Agee, A. Auton, R. K. Bell, Katarzyna Bryc, Sarah L. Elson et al. · 2019 · npj Parkinson s Disease
77. A Dual Centre Study of Pain in Parkinson’s Disease and Its Relationship with Other Non-Motor Symptoms
    Pritha Ghosh, Paola Imbriani, Nicoletta Caputi, Silvia Natoli, Tommaso Schirinzi, Giulia Di Lazzaro, Lindsey Covington, Andrew Dunn Sparks, Yekaterina Salnikova, Katarina Rukavina et al. · 2020 · Journal of Parkinson s Disease
78. Comparison of 123I-MIBG scintigraphy and phosphorylated α-synuclein skin deposits in synucleinopathies
    Maria Pia Giannoccaro, Vincenzo Angelo Donadio, Giulia Giannini, Grazia Devigili, Giovanni Rizzo, Alex Incensi, Ernesto Cason, Giovanna Calandra Buonaura, Roberto Eleopra, Pietro Cortelli et al. · 2020 · Parkinsonism & Related Disorders
79. Cognitive effects of theta frequency bilateral subthalamic nucleus stimulation in Parkinson’s disease: A pilot study
    Jordan Lam, Justin Lee, Marcus Williams, Mélanie Cohn, Melissa L. Wilson, Catherine Mark, Nasrin Esnaashari, Andrew John Petkus, Jennifer S. Hui, Danielle Feigenbaum et al. · 2021 · Brain stimulation
80. Impact of SAfinamide on Depressive Symptoms in Parkinson’s Disease Patients (SADness-PD Study): A Multicenter Retrospective Study
    Esteban Peña, Carmen Borrué, Marina Mata, Juan Carlos Martínez‐Castrillo, Araceli Alonso Cánovas, J J Ampuero Chico, Lydia López Manzanares, Marcos Llanero Luque, Jaime Herreros Rodríguez, Alberto Esquivel et al. · 2021 · Brain Sciences
81. Global Variability in Deep Brain Stimulation Practices for Parkinson’s Disease
    Abhimanyu Mahajan, Ankur Butala, Michael S. Okun, Zoltan K. Mari, Kelly A. Mills · 2021 · Frontiers in Human Neuroscience
82. Video-based Parkinson’s disease assessments in a nationwide cohort of Fox Insight participants
    Taylor L. Myers, Christopher G. Tarolli, Jamie Adams, Richard L. Barbano, María Cristina Gil-Díaz, Kelsey L. Spear, Jill Lowell, Margaret Daeschler, Lindsey Riley, Ninad Amondikar et al. · 2021 · Clinical Parkinsonism & Related Disorders
83. Comparison of Different Platform Immunoassays for the Measurement of Plasma Alpha-Synuclein in Parkinson’s Disease Patients
    Priscilla Youssef, Woojin Scott Kim, Glenda Margaret Halliday, Simon J.G. Lewis, Nicolas L. Dzamko · 2021 · Journal of Parkinson s Disease
84. The Views and Needs of People With Parkinson Disease Regarding Wearable Devices for Disease Monitoring: Mixed Methods Exploration
    Lorna Kenny, Kevin Moore, Clíona O' Riordan, Siobhán Fox, John J. Barton, Salvatore Antonio Tedesco, Marco Sica, Colum Crowe, Antti Alamäki, Joan V. Condell et al. · 2022 · JMIR Formative Research
85. Advances in dementia with Lewy bodies
    Melissa J. Armstrong · 2021 · Therapeutic Advances in Neurological Disorders
86. Biallelic expansion in RFC1 as a rare cause of Parkinson’s disease
    Laura Kytövuori, Jussi Sipilä, Hiroshi Doi, Anri Hurme‐Niiranen, Ari Siitonen, Eriko Koshimizu, Satoko Miyatake, Naomichi Matsumoto, Fumiaki Tanaka, Kari Majamaa · 2022 · npj Parkinson s Disease
87. Genotype-phenotype correlation of Parkinson's disease with PRKN variants
    Hiroyo Yoshino, Yuanzhe Li, Kenya Nishioka, Kensuke Daida, Arisa Hayashida, Yuta Ishiguro, Daisuke Yamada, Nana Izawa, Katsunori Nishi, Noriko Nishikawa et al. · 2022 · Neurobiology of Aging
88. A Wearable Gait Analysis and Recognition Method for Parkinson’s Disease Based on Error State Kalman Filter
    Ruichen Liu, Zhelong Wang, Sen Qiu, Hongyu Zhao, Cui Wang, Xin Shi, Fang Lin · 2022 · IEEE Journal of Biomedical and Health Informatics
89. Video-Based Automated Assessment of Movement Parameters Consistent with MDS-UPDRS III in Parkinson’s Disease
    Gaëtan Vignoud, Clément Desjardins, Quentin Salardaine, Marie Mongin, Béatrice Garcin, Laurent Venance, Bertrand Degos · 2022 · Journal of Parkinson s Disease
90. Age and sex differentially shape brain networks in Parkinson's disease
    Zhichun Chen, Bin Wu, Guanglu Li, Liche Zhou, Lina Zhang, Jun Liu · 2023 · CNS Neuroscience & Therapeutics
91. Parkinsonian Hand or Clinician’s Eye? Finger Tap Bradykinesia Interrater Reliability for 21 Movement Disorder Experts
    Stefan Williams, David Wong, Jane Alty, Samuel David Relton · 2023 · Journal of Parkinson s Disease
92. Clinical features, MRI, and 18F‐FDG‐PET in differential diagnosis of Parkinson disease from multiple system atrophy
    Zhao, Ping, Zhang, Benshu, Gao, Shuo, Li, Xin · 2020 · Brain and Behavior
93. Emerging Promise of Nanoparticle-Based Treatment for Parkinson’s disease
    2020 · Biointerface Research in Applied Chemistry
94. Changes of T lymphocyte subpopulations and their roles in predicting the risk of Parkinson’s disease
    Yijing He, Kangwen Peng, Ruoyu Li, Zhuoyu Zhang, Lizhen Pan, Tianyu Zhang, Ao Lin, Ronghua Hong, Zhiyu Nie, Qiang Guan et al. · 2022 · Journal of Neurology
95. Bidirectional Relationship Between Sleep Disturbances and Parkinson's Disease
    Eiko Nakano Minakawa · 2022 · Frontiers in Neurology
96. Mind–Body Exercises for Non-motor Symptoms of Patients With Parkinson’s Disease: A Systematic Review and Meta-Analysis
    Kai Wang, Kunbin Li, Peiming Zhang, Shuqi Ge, Xiaopeng Wen, Zhiyuan Wu, Xianli Yao, Bing Jiao, Pingge Sun, Peipei Lv et al. · 2021 · Frontiers in Aging Neuroscience
97. Artificial intelligence-based clustering and characterization of Parkinson's disease trajectories
    Colin J. Birkenbihl, Ashar Ahmad, Nathalie J. Massat, Tamara Raschka, Andreja Avberšek, Patrick Mark Downey, Martin Armstrong, Holger Fröhlich · 2023 · Scientific Reports
98. Optical coherence tomography angiography measurements in Parkinson’s disease: A systematic review and meta-analysis
    Mohammad Amin Salehi, Fateme Rezagholi, Soheil Mohammadi, Seyed Sina Zakavi, Ali Jahanshahi, Mahdi Gouravani, Ghasem Yazdanpanah, Ian A. Seddon, Sayena Jabbehdari, Rishi P. Singh · 2023 · Eye
99. Neurofilament Light Protein Predicts Disease Progression in Idiopathic REM Sleep Behavior Disorder
    Xuan Zhang, Li Ma, Danqi Liang, Bingxin Song, Jingshan Chen, Yaqin Huang, Lin Xu, Peng Zhao, Wei Wu, Nan Zhang et al. · 2023 · Journal of Parkinson s Disease
100. System Integrated Digital Empowering and teleRehabilitation to promote patient Activation and well-Being in chronic disabilities: A usability and acceptability study
     Federica Rossetto, Francesca Borgnis, Sara Isernia, Emanuela Foglia, Elisabetta Garagiola, Olivia Realdon, Francesca Baglio · 2023 · Frontiers in Public Health